Credit score: Elkor/Getty Photos
LICORbio acquired Serva Electrophoresis, a privately held firm based in 1953 and which supplies electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s place as a options supplier in protein evaluation, mentioned Tom Reslewic, CEO of LICORbio.
The combination of SERVA’s applied sciences with LICORbio’s imaging platforms will present prospects with full workflow options from pattern preparation to decision, to imaging and quantification, added Reslewic.
“This acquisition displays LICORbio’s strategic deal with increasing our core applied sciences whereas staying near the wants of the analysis group,” he continued. “By integrating SERVA’s expansive electrophoresis merchandise with our established imaging platforms, we’re enabling extra correct, reproducible, and environment friendly protein, DNA, and RNA evaluation workflows.”
The acquisition is efficient instantly, with integration actions already underway. As a part of the acquisition, LICORbio will preserve Serva’s Heidelberg location.
